**Waters Corporation (WAT) reported second-quarter 2026 earnings of $3.05 per share, marking a 3.4% increase year over year and exceeding the Zacks Consensus Estimate by 1.33%. The company achieved revenues of $1.645 billion, a remarkable 113.4% surge from the previous year, surpassing expectations by 1.25%. Organic revenues increased by 9% in constant currency, with the acquired Biosciences and Diagnostic Solutions businesses contributing $817 million, exceeding guidance by $15 million.**
**The Analytical Sciences division generated $669 million, with significant growth in instruments (8%), chemistry (10%), and service (9%). The Biosciences Division saw revenues rise to $368 million, while Advanced Diagnostics achieved $521 million. Waters raised its 2026 guidance, now projecting organic constant-currency revenue growth of 7%-9% and adjusted earnings of $14.45-$14.65 per share.**
**As of July 4, 2026, Waters had cash and cash equivalents of $539 million and total debt of $5.09 billion, largely due to the Biosciences acquisition. The company plans to help drive additional growth by launching new products and is on track to achieve $50 million in revenue synergies in 2026.**
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
